Renin‐Angiotensin Aldosterone System Inhibitors and COVID‐19: A Systematic Review and Meta‐Analysis Revealing Critical Bias Across a Body of Observational Research

Background Renin‐angiotensin aldosterone system (RAAS) inhibitor—COVID‐19 studies, observational in design, appear to use biased methods that can distort the interaction between RAAS inhibitor use and COVID‐19 risk. This study assessed the extent of bias in that research and reevaluated RAAS inhibit...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Jordan Loader, Frances C. Taylor, Erik Lampa, Johan Sundström
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	Wiley 2022-06-01
Cyfres:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Pynciau:	angiotensin receptor blockers angiotensin‐converting enzyme inhibitors calcium channel blockers COVID‐19 renin‐aldosterone angiotensin system inhibitors thiazide diuretics
Mynediad Ar-lein:	https://www.ahajournals.org/doi/10.1161/JAHA.122.025289
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!